期刊文献+

老年患者分离嗜麦芽寡养单胞菌的临床分布及耐药性监测 被引量:5

Distribution and antimicrobial resistance of Stenotrophomonas maltophilia isolated from senile patients
原文传递
导出
摘要 目的调查老年患者临床分离嗜麦芽寡养单胞菌的分布及对抗菌药物的敏感性,为临床合理使用抗菌药物提供依据。方法对医院2008年1月-2010年12月临床分离出嗜麦芽寡养单胞菌的老年患者进行病例回顾性分析,应用ATB Expression自动细菌鉴定系统对菌种进行鉴定,用K-B纸片扩散法对病原菌进行药物敏感性试验,按CLSI 2008年规定标准进行判断。结果从临床标本中共分离出嗜麦芽寡养单胞菌658株,其中标本90.1%来自呼吸道、2.6%来自体液、2.4%来自血液、2.1%来自尿液;老年患者均患有原发基础疾病,其中患≥2种基础疾病者占83.4%;老年患者嗜麦芽寡养单胞菌感染的危险因素为不合理使用抗菌药物、侵入性诊疗措施及住院时间长等;米诺环素和磺胺甲噁唑/甲氧苄啶对嗜麦芽寡养单胞菌的抗菌活性最强,耐药率分别为1.6%~4.7%和3.9%~12.5%。结论临床分离的嗜麦芽寡养单胞菌日益增多,由于嗜麦芽寡养单胞菌具有固有的广谱耐药特性,给临床治疗造成很大困难,因此,应重视嗜麦芽寡养单胞菌的监测和药敏试验,严格执行消毒隔离制度,临床医师应根据药敏试验结果,合理选用抗菌药物,减少老年患者嗜麦芽寡养单胞菌感染的发生率。 OBJECTIVE To investigate the distribution and antimicrobial resistance of Stenotrophomonas maltophil- ia isolates in senile patients so as to guide the rational use of antibiotics. METHODS The clinical isolates of the S. maltophilia isolated from the senile patients from Jan 2008 to Dec 2010 were retrospectively analyzed, The identifi- cation was analyzed by ATB Expression automatic microbiology analytical instrument system. The Kirby-Bauer agar diffusion method was applied for the antibiotic susceptibility testing and the results were read based on CLSI (2008) standards. RESULTS A total of 658 pathogen strains were isolated, among which 90.1% of the isolates were from sputum specimens, 2.6% from body fluid, 2.4% from blood, and 2.1% from urine. All the elderly patients suffered from underlying disease, 83.4% of the patients sufferred from two or more than two kinds of underlying diseases. The risk factors leading to the S. maltophilia infections were the unreasonable use of antibiot- ics ,invasive operation, and long hospitalization duration. The result of drug susceptibility testing indicated that the minocycline and trimethoprim/sulfamethoxazole showed great antibacterial activity against the S. maltophilia strains, with the drug resistance rates respectively varying from 1. 6% to 4. 70% and from 3. 9% to 12. 5%. CONCLUSION The clinical isolates of the S. maltophilia are increasing. As the S. maltophilia possesses the intrinsic broad-spectrum resistance, the clinical treatment is very difficult. We should pay much attention to the detection of S. maltophilia strains and their antimicrobial susceptibility. Furthermore, stringently executing institution of disinfection and isolation is also important. It is necessary for the clinicians to reasonably use antibiotics based on the result of drug sensitivity testing so as to reduce the incidence of S. maltophilia infections in the senile patients.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第7期1704-1706,共3页 Chinese Journal of Nosocomiology
关键词 嗜麦芽寡养单胞菌 分布 耐药性 抗菌药物 Stenotrophomonas maltophilia Distribution Drug resistance Antibiotics
  • 相关文献

参考文献8

  • 1刘蓬蓬,何宏,任立晟,韩春华,刘梦阳,朱元祺.临床感染常见革兰阴性杆菌的分布及耐药性监测[J].中华医院感染学杂志,2011,21(5):982-985. 被引量:10
  • 2Clinical and Laboratory Standards Institute. Performance Stand-ards for Antimicrobial Susceptibility Testing [S]. Ml 00-SI 8. Fif-teenth Informational Supplement, 2008.
  • 3刘蓬蓬,刘广义,赵金霞.老年常见病与护理[M].北京:社会科学文献出版社,2010.
  • 4Farrell DJ, Sader HS,Jones RN. Antimicrobial susceptibili-ties of Stenotrophomonas maltophilia isolates tested againsttigecycline and agents commonly used for S. maltophilia in-fections [J ].Antimicrob Agents Chemother, 2010, 54 ( 6 ):2735-2737.
  • 5Toleman MA,Bennett PM,Bennett DM,etal. Global emergenceof trimethoprim/sulfamethoxazole resistance in Stenotrophomonasmaltophilia mediated by acquisition of sul genes[J]. Emerg InfectDis,2007,13(4) :559-565.
  • 6Korakianitis I, Mirtsou V, Gougoudi E, et al. Post-antibioticeffect (PAE) of moxifloxacin in multidrug-resistant Stenotro-phomonas maltophilia[J]. J Antimicrob Agents,2010,36(4):387-389.
  • 7Pompilio A,Catavitello C,Picciani C,etal. Subinhibitory concen-trations of moxifloxacin decrease adhesion and biofilm formation ofStenotrophomonas maltophilia from cystic fibrosis[J]. J Med Mi-crobiol,2010,59(1) :76-81.
  • 8Wood GC, Underwood EL, Croce MA, et al. Treatment ofrecurrent Stenotrophomonas maltophilia ventilator-associatedpneumonia with doxycycline and aerosolized colistin[J], AnnPharmacother,2010,44( 10) : 1665-1668.

二级参考文献10

  • 1Clinical and Laboratory Standards Institute. Performance Standards for Antimierobial Susceptibility Testing [S]. M100-S18. Fifteenth Informational Supplement, 2008.
  • 2Woodford N, Tierno PM, Young K, etal. Outbreak of Klebsiella pneurnoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KP-3, in a New York Medical Center[J]. Antimicrob Agents Chemother,2004,48(12) :4793-4799.
  • 3Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KP-2 in a Klebsiella pneumoniae isolate from China[J]. Antimierob Agents Chemother, 2007,51(2) : 763-765.
  • 4Woodford N, Zhang J, Warner M, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom[J]. J Antimicrob Chemother, 2008,62(6):1261- 1264.
  • 5Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae[J]. J Clin Microbiol, 2007,45 (8) :2723-2725.
  • 6Clinical and Laboratory Standards Institute. Performance Stand- ards for Antimicrobial Susceptibility Testing [S]. Nineteenth Informational Supplement, 2009, M100-S19:125.
  • 7Hospital-acquired pneumonia guideline committee of the American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and heahhcare-associated pneumonia [ J ]. Am J Respir Crit Care Med, 2005,171 : 388-416.
  • 8Lee SO, Kim NJ, Choi SH, etal. Risk factors for acquisition of imipenem resistant Acinetobacter baumannii : a case-control study[J]. Antimicrob Agents Chemother, 2004,48 (1) : 224- 228.
  • 9Holloway KP, Rouphael NG, Wells JB,et al. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baurnannii infections in the intensive care unit [J]. Ann Pharmacother, 2006,40(11) : 1939-1945.
  • 10刘蓬蓬,初开秋,朱元祺,翟赞亮,苏维奇,梁冰,孙英姿.青岛地区革兰阴性杆菌的分布及耐药性监测[J].中华医院感染学杂志,2007,17(9):1138-1140. 被引量:7

共引文献9

同被引文献41

  • 1叶礼岳,王史辉,潘君泰,林邦长,郑金满,孙菊妹.严重烧伤后发生嗜麦芽窄食单胞菌菌血症12例分析[J].浙江医学,2006,28(12):1008-1009. 被引量:1
  • 2邓笑伟,刘长庭,李天智,王俊锋,粱立武,黄燕萍,莫晨.嗜麦芽寡养单胞菌中Ⅱ类整合酶基因的发现及意义[J].中华医院感染学杂志,2007,17(9):1061-1063. 被引量:19
  • 3Samonis G, Karageorgopoulos D E, Maraki S,et al.Stenotrophomonas maltophilia infections in a generalhospital: patient characteristics,antimicrobial suscepti-bility, and treatment outcome [J]. PLoS One, 2012,7(5):373-375.
  • 4DiBonaventura G,Spedicato I,D7Antonio T),et al.Biofilmformation by stenotrophomonas maltophilia: modulationby quinolones,trimethoprim - sulfamethoxazole,andceftazidime[J]. Antimicrob Agents Chemother,2004, 48(I):151-160.
  • 5GasinkL B, Edelstein P H, Lautenbac H E, et al. Riskfactors and clinical impact of Klebsiella pneumoniae car-bapenemase- producting K. pneumoniae[J]. Infect Con-trol Hosp Epidemiol,2009 ,30(12) : 1180 - 1185.
  • 6DrorM,Shift N V,David S,et al.Surveillance culturesand duration of carriage of multidrug-resistant Acine-tobacter baumannii[J].Clin Microbiol, 2007,45 : 1551 -1555.
  • 7Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing;Twenty- Fourth Informational Supplement[ S ].M 100-$24, CLSI.2014.
  • 8Brooke JS.Stenotrophomonas mahophilia: An emerging global opportunistic pathogen [ J ].Clin Microbiol Rev, 2012,25 ( 1 ) : 2-41.
  • 9Sanchez MB,Hernandez A,Martinez JL.Stenotrophomonas maltophilia drug resistance [ J ].Future Microbiol, 2009,4(6) : 655-660.
  • 10Hu LF,Chang X,Ye Y,et al.Stenotrophomonas mahophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class I integron [ J ].Int J Antimicrob Agents, 2011,37 (3) : 230-234.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部